Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences Biomarkers - From Research To Commercialization
Conferences  \  Biomarkers - From Research To Commercialization  \  Agenda  \  Michael Lutz
RegisterLogin

Michael Lutz's Biography


Michael Lutz, CEO, LifeCodexx

Michael Lutz is an experienced biotech entrepreneur who has extensive experience in the build-up and management of biotech companies. Following various management positions at Novartis Pharma and Evotec Michael has successfully built up six biotech companies over the last 10 years. Four of these companies were sold to publicly traded biotech companies. His current focus is in the area of prenatal diagnosis where he acts as CEO of LifeCodexx AG since 2010.

Michael Lutz Image

Taking NIPT to the Next Level: Detection of Fetal Trisomy by qPCR

Friday, 25 May 2018 at 12:35

Add to Calendar ▼2018-05-25 12:35:002018-05-25 13:35:00Europe/LondonTaking NIPT to the Next Level: Detection of Fetal Trisomy by qPCRBiomarkers - From Research To Commercialization in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonBiomarkers - From Research To CommercializationBiomarkers - From Research To Commercialization in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com


Conference Sponsors
Related Conferences
Emerging Technologies for Diagnostics & Liquid Biopsies - New Orleans 2024
Location: New Orleans
Date: 26/09/2024 - 27/09/2024


Innovations in Microfluidics 2024: Rapid Prototyping, 3D-Printing
Location: Ann Arbor, Michigan
Date: 06/05/2024 - 07/05/2024


Lab-on-a-Chip and Microfluidics Europe 2024
Location: Rotterdam, The Netherlands
Date: 24/06/2024 - 25/06/2024